ADAMTS4
Basic information
Region (hg38): 1:161184302-161199054
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (118 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAMTS4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005099.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 113 | 119 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 113 | 7 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADAMTS4 | protein_coding | protein_coding | ENST00000367996 | 9 | 14749 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000195 | 0.999 | 125679 | 0 | 69 | 125748 | 0.000274 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.15 | 454 | 529 | 0.859 | 0.0000328 | 5321 |
Missense in Polyphen | 170 | 219.24 | 0.77542 | 2269 | ||
Synonymous | 0.587 | 209 | 220 | 0.950 | 0.0000133 | 1829 |
Loss of Function | 2.85 | 15 | 32.5 | 0.461 | 0.00000173 | 337 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000905 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000656 | 0.000653 |
Finnish | 0.000631 | 0.000601 |
European (Non-Finnish) | 0.000268 | 0.000264 |
Middle Eastern | 0.000656 | 0.000653 |
South Asian | 0.000294 | 0.000294 |
Other | 0.000492 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Cleaves aggrecan, a cartilage proteoglycan, and may be involved in its turnover. May play an important role in the destruction of aggrecan in arthritic diseases. Could also be a critical factor in the exacerbation of neurodegeneration in Alzheimer disease. Cleaves aggrecan at the '392-Glu-|-Ala-393' site.;
- Pathway
- Endochondral Ossification;Post-translational protein modification;Metabolism of proteins;Extracellular matrix organization;Degradation of the extracellular matrix;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.193
Intolerance Scores
- loftool
- 0.447
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.71
Haploinsufficiency Scores
- pHI
- 0.0847
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.172
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adamts4
- Phenotype
- renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- skeletal system development;proteolysis;extracellular matrix disassembly
- Cellular component
- extracellular region;extracellular space;nuclear speck;collagen-containing extracellular matrix
- Molecular function
- protease binding;metalloendopeptidase activity;protein binding;peptidase activity;metallopeptidase activity;metal ion binding